1,128
Views
9
CrossRef citations to date
0
Altmetric
Addendum

Glyco-engineering for the production of recombinant IgA1 with distinct mucin-type O-glycans in plants

, &
Pages 484-489 | Received 31 May 2016, Accepted 08 Jun 2016, Published online: 19 Aug 2016

References

  • Helenius A, Aebi M. Intracellular functions of N-linked glycans. Science 2001; 291:2364-9; PMID:11269317; http://dx.doi.org/10.1126/science.291.5512.2364
  • Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer 2015; 15:540-55; PMID:26289314; http://dx.doi.org/10.1038/nrc3982
  • Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 2007; 25:21-50; PMID:17029568; http://dx.doi.org/10.1146/annurev.immunol.25.022106.141702
  • Shields RL, Lai J, Keck R, O'Connell LY, Hong K, Meng YG, Weikert SH, Presta LG. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem 2002; 277:26733-40; PMID:11986321; http://dx.doi.org/10.1074/jbc.M202069200
  • Strasser R. Engineering of human-type O-glycosylation in Nicotiana benthamiana plants. Bioengineered 2013; 4:191-6; PMID:23147167; http://dx.doi.org/10.4161/bioe.22857
  • Yang Z, Wang S, Halim A, Schulz MA, Frodin M, Rahman SH, Vester-Christensen MB, Behrens C, Kristensen C, Vakhrushev SY, et al. Engineered CHO cells for production of diverse, homogeneous glycoproteins. Nat Biotechnol 2015; 33:842-4; PMID:26192319; http://dx.doi.org/10.1038/nbt.3280
  • Strasser R, Altmann F, Steinkellner H. Controlled glycosylation of plant-produced recombinant proteins. Curr Opin Biotechnol 2014; 30C:95-100; http://dx.doi.org/10.1016/j.copbio.2014.06.008
  • Dicker M, Tschofen M, Maresch D, König J, Juarez P, Orzaez D, Altmann F, Steinkellner H, Strasser R. Transient Glyco-Engineering to Produce Recombinant IgA1 with Defined N- and O-Glycans in Plants. Front Plant Sci 2016; 7:18; PMID:26858738; http://dx.doi.org/10.3389/fpls.2016.00018
  • Bennett EP, Mandel U, Clausen H, Gerken TA, Fritz TA, Tabak LA. Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family. Glycobiology 2012; 22:736-56; PMID:22183981; http://dx.doi.org/10.1093/glycob/cwr182
  • Ju T, Cummings RD. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β 3-galactosyltransferase. Proc Natl Acad Sci U S A 2002; 99:16613-8; PMID:12464682; http://dx.doi.org/10.1073/pnas.262438199
  • Johansen FE, Braathen R, Brandtzaeg P. Role of J chain in secretory immunoglobulin formation. Scand J Immunol 2000; 52:240-8; PMID:10972899; http://dx.doi.org/10.1046/j.1365-3083.2000.00790.x
  • Woof JM, Mestecky J. Mucosal immunoglobulins. Immunol Rev 2005; 206:64-82; PMID:16048542; http://dx.doi.org/10.1111/j.0105-2896.2005.00290.x
  • Ju T, Otto VI, Cummings RD. The Tn antigen-structural simplicity and biological complexity. Angew Chem Int Ed Engl 2011; 50:1770-91; PMID:21259410; http://dx.doi.org/10.1002/anie.201002313
  • Knoppova B, Reily C, Maillard N, Rizk DV, Moldoveanu Z, Mestecky J, Raska M, Renfrow MB, Julian BA, Novak J. The origin and activities of IgA1-Containing immune complexes in IgA Nephropathy. Front Immunol 2016; 7:117; PMID:27148252; http://dx.doi.org/10.3389/fimmu.2016.00117
  • Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001; 59:1077-85; PMID:11231363; http://dx.doi.org/10.1046/j.1523-1755.2001.0590031077.x
  • Lehoux S, Mi R, Aryal RP, Wang Y, Schjoldager KT, Clausen H, van Die I, Han Y, Chapman AB, Cummings RD, et al. Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin A (IgA) nephropathy and healthy individuals. Mol Cell Proteomics 2014; 13:3097-113; PMID:25071157; http://dx.doi.org/10.1074/mcp.M114.039693
  • Takahashi K, Raska M, Stuchlova Horynova M, Hall SD, Poulsen K, Kilian M, Hiki Y, Yuzawa Y, Moldoveanu Z, Julian BA, et al. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy. PLoS One 2014; 9:e99026; PMID:24918438; http://dx.doi.org/10.1371/journal.pone.0099026
  • Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 2009; 119:1668-77; PMID:19478457
  • Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 1999; 104:73-81; PMID:10393701; http://dx.doi.org/10.1172/JCI5535
  • Yoo EM, Morrison SL. IgA: an immune glycoprotein. Clin Immunol 2005; 116:3-10; PMID:15925826; http://dx.doi.org/10.1016/j.clim.2005.03.010
  • Leung JC, Poon PY, Lai KN. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy? J Lab Clin Med 1999; 133:152-60; PMID:9989767; http://dx.doi.org/10.1016/S0022-2143(99)90008-2
  • Hiki Y. O-linked oligosaccharides of the IgA1 hinge region: roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy. Clin Exp Nephrol 2009; 13:415-23; PMID:19365705; http://dx.doi.org/10.1007/s10157-009-0173-7
  • Barratt J, Smith AC, Feehally J. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy. Nephrology (Carlton) 2007; 12:275-84; PMID:17498123; http://dx.doi.org/10.1111/j.1440-1797.2007.00797.x
  • Saito F, Suyama A, Oka T, Yoko-O T, Matsuoka K, Jigami Y, Shimma YI. Identification of Novel Peptidyl Serine α-Galactosyltransferase gene family in plants. J Biol Chem 2014; 289:20405-20; PMID:24914209; http://dx.doi.org/10.1074/jbc.M114.553933
  • Karnoup AS, Turkelson V, Anderson WH. O-linked glycosylation in maize-expressed human IgA1. Glyco Biol 2005; 15:965-81; PMID:15901675; http://dx.doi.org/10.1093/glycob/cwi077
  • Parsons J, Altmann F, Graf M, Stadlmann J, Reski R, Decker EL. A gene responsible for prolyl-hydroxylation of moss-produced recombinant human erythropoietin. Sci Rep 2013; 3:3019; PMID:24145658; http://dx.doi.org/10.1038/srep03019
  • Castilho A, Neumann L, Daskalova S, Mason HS, Steinkellner H, Altmann F, Strasser R. Engineering of Sialylated Mucin-type O-Glycosylation in Plants. J Biol Chem 2012; 287:36518-26; PMID:22948156; http://dx.doi.org/10.1074/jbc.M112.402685
  • Juarez P, Huet-Trujillo E, Sarrion-Perdigones A, Falconi EE, Granell A, Orzaez D. Combinatorial analysis of secretory immunoglobulin A (sIgA) expression in plants. Int J Mol Sci 2013; 14:6205-22; PMID:23507755; http://dx.doi.org/10.3390/ijms14036205
  • Dicker M, Schoberer J, Vavra U, Strasser R. Subcellular targeting of proteins involved in modification of plant N- and O-Glycosylation. Methods Mol Biol 2015; 1321:249-67; PMID:26082228; http://dx.doi.org/10.1007/978-1-4939-2760-9_18
  • Suzuki Y, Suzuki H, Yasutake J, Tomino Y. Paradigm shift in activity assessment of IgA nephropathy - optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting. Expert Opin Biol Ther 2015; 15:583-93; PMID:25604055; http://dx.doi.org/10.1517/14712598.2015.1006624